Literature DB >> 9694720

Aberrant and unstable expression of immunoglobulin genes in persons infected with human immunodeficiency virus.

A Bessudo1, L Rassenti, D Havlir, D Richman, E Feigal, T J Kipps.   

Abstract

We examined the IgM VH gene subgroup use-distribution in serial blood samples of 37 human immunodeficiency virus (HIV)-infected patients and a group of HIV-seronegative healthy adults. The IgM VH gene repertoires of healthy adults were relatively similar to one another and were stable over time. In contrast, individuals infected with HIV had IgM VH gene repertoires that were significantly more heterogeneous and unstable. Persons at early stages of HIV infection generally had abnormal expression levels of Ig VH3 genes and frequently displayed marked fluctuations in the relative expression levels of this VH gene subgroup over time. In contrast, persons with established acquired immunodeficiency syndrome (AIDS) had a significantly lower incidence of abnormalities in Ig VH3 expression levels, although continued to display abnormalities and instability in the expression levels of the smaller Ig VH gene subgroups. Moreover, the skewing and/or fluctuations in the expressed-IgM VH gene repertoire appeared greatest for persons at earlier stages of HIV infection. These studies show that persons infected with HIV have aberrant and unstable expression of immunoglobulin genes suggestive of a high degree humoral immune dysregulation and ongoing humoral immune responses to HIV-associated antigens and superantigens. Copyright 1998 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9694720

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  7 in total

1.  Specific in vivo deletion of B-cell subpopulations expressing human immunoglobulins by the B-cell superantigen protein L.

Authors:  Muriel Viau; Nancy S Longo; Peter E Lipsky; Lars Björck; Moncef Zouali
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

2.  Molecular determinants of the human antibody response to HIV-1: implications for disease control.

Authors:  M Viau; M Zouali
Journal:  J Clin Immunol       Date:  2001-11       Impact factor: 8.317

3.  Cryptococcus neoformans-reactive and total immunoglobulin profiles of human immunodeficiency virus-infected and uninfected Ugandans.

Authors:  Krishanthi Subramaniam; Neil French; Liise-Anne Pirofski
Journal:  Clin Diagn Lab Immunol       Date:  2005-10

4.  Long-term kinetics of adult human antibody repertoires.

Authors:  Iris Van Dijk-Härd; Inger Lundkvist
Journal:  Immunology       Date:  2002-09       Impact factor: 7.397

5.  Protective and nonprotective human immunoglobulin M monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan manifest different specificities and gene use profiles.

Authors:  Robert W Maitta; Kausik Datta; Qing Chang; Robin X Luo; Bradley Witover; Krishanthi Subramaniam; Liise-anne Pirofski
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

6.  Humoral response against Cryptococcus neoformans mannoprotein antigens in HIV-infected patients.

Authors:  L Pitzurra; S Perito; F Baldelli; F Bistoni; A Vecchiarelli
Journal:  Clin Exp Immunol       Date:  2003-07       Impact factor: 4.330

7.  Biased use of the IGHV4 family and evidence for antigen selection in Chlamydophila psittaci-negative ocular adnexal extranodal marginal zone lymphomas.

Authors:  Daxing Zhu; Chen Lossos; Jennifer R Chapman-Fredricks; Julie M Matthews; Offiong F Ikpatt; Phillip Ruiz; Izidore S Lossos
Journal:  PLoS One       Date:  2011-12-27       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.